Recombinant Human GRIPAP1 Protein: Research Guide
Recombinant Human GRIPAP1 Protein: Research Guide
Recombinant Human GRIPAP1 Protein is a research-grade reagent designed to support investigation of GRIP-associated protein 1 function in synaptic organization, intracellular trafficking, and AMPA receptor regulation.
- Protein Name
- GRIPAP1 (GRIP-Associated Protein 1), also known as GRASP1
- Species Origin
- Human (Homo sapiens)
- Protein Form
- Recombinant protein produced in a heterologous expression system
- Primary Application
- In vitro biochemical assays, protein interaction studies, antibody validation, and neuroscience research
- Product SKU
- rp370892
- Supplier Reference
- absea#PP-5106
What Is GRIPAP1? Biological Background
GRIPAP1, commonly referred to as GRASP1 (GRIP-Associated Protein 1), is an intracellular scaffolding protein that plays a central role in the trafficking and recycling of AMPA-type glutamate receptors (AMPARs) at neuronal synapses. It was originally identified through its interaction with GRIP (Glutamate Receptor Interacting Protein), a multi-PDZ domain scaffold protein critical for glutamatergic synaptic transmission.
GRIPAP1 contains a RasGEF-like domain, coiled-coil regions, and multiple protein–protein interaction motifs, which collectively facilitate its function as a molecular hub coordinating vesicular trafficking pathways. Through these interactions, GRIPAP1 influences synaptic plasticity processes such as long-term potentiation (LTP) and long-term depression (LTD), which are fundamental to learning and memory.
Beyond its neuronal roles, GRIPAP1 has been implicated in endosomal sorting and intracellular membrane trafficking in non-neuronal cells, suggesting a broader function in cellular homeostasis. Its expression is enriched in the brain, particularly in regions associated with cognition and memory, including the hippocampus and cortex.
Biochemical Properties and Recombinant Protein Production
Recombinant Human GRIPAP1 Protein (SKU: rp370892) is produced using established recombinant expression technologies to deliver a consistent, research-grade material suitable for demanding in vitro applications. The recombinant format ensures batch-to-batch reproducibility, which is essential for quantitative biochemical assays and comparative studies.
Key structural features of GRIPAP1 relevant to researchers include its modular domain architecture: the N-terminal region harbors a RasGEF homology domain, while C-terminal coiled-coil segments mediate oligomerization and protein–protein interactions. These domains are critical targets for researchers studying AMPAR trafficking, endosomal sorting signals, or scaffolding protein networks at the postsynaptic density.
Researchers should consult the product datasheet for confirmed details on expression host, tag configuration, molecular weight, purity grade, buffer formulation, and recommended storage conditions. Specific lot-dependent quality control data, including SDS-PAGE purity and functional assay results, are provided with each shipment.
Research Applications
Recombinant Human GRIPAP1 Protein is suitable for a range of in vitro research applications, including but not limited to:
- Protein–Protein Interaction Studies: Use in pull-down assays, co-immunoprecipitation validation, and surface plasmon resonance (SPR) or bio-layer interferometry (BLI) experiments to characterize binding partners such as GRIP1/2, Rab GTPases, and AMPAR subunits.
- Antibody Validation: Serves as a positive control antigen for validating anti-GRIPAP1 antibodies in ELISA, Western blot, and immunofluorescence workflows.
- Biochemical Assays: Can be employed in enzymatic activity assays or structural studies if functional activity is confirmed; researchers should verify activity data in the product datasheet.
- Drug Discovery and Screening: Suitable as a target protein in small-molecule binding screens relevant to synaptic biology or neurological disease research.
- Cell Biology Research: Supports in vitro reconstitution experiments examining AMPAR recycling and endosomal trafficking mechanisms.
As with all recombinant proteins, optimization of assay conditions—including buffer composition, protein concentration, and temperature—is recommended to achieve best performance in specific experimental contexts.
Handling, Storage, and Quality Considerations
Proper handling and storage of Recombinant Human GRIPAP1 Protein are essential to preserve biological activity and ensure experimental reproducibility. General best-practice guidelines for recombinant proteins apply:
- Storage: Store at the temperature specified in the product datasheet, typically −20 °C or −80 °C for long-term preservation. Avoid repeated freeze–thaw cycles, which can lead to aggregation and loss of activity.
- Aliquoting: Upon receipt, it is advisable to prepare single-use aliquots to minimize freeze–thaw stress on the remaining stock.
- Working Conditions: Thaw on ice and keep on ice during use. Centrifuge briefly before opening to collect material from the tube walls.
- Quality Control: Each lot is subject to quality control testing. Confirm purity (typically assessed by SDS-PAGE and/or HPLC), identity (confirmed by mass spectrometry or Western blot), and endotoxin levels in the accompanying Certificate of Analysis (CoA).
If unusual aggregation, precipitation, or unexpected activity is observed, contact Aladdin Scientific technical support for guidance. All specific storage temperatures, buffer compositions, and shelf-life data are provided on the individual product datasheet and CoA.
Ordering Information
Recombinant Human GRIPAP1 Protein is available from Aladdin Scientific. Please refer to the table below for ordering details:
| SKU | Product Name | Supplier Reference |
|---|---|---|
| rp370892 | Recombinant Human GRIPAP1 Protein | absea#PP-5106 |
For bulk quantities, custom formulations, or questions regarding availability and pricing, please contact Aladdin Scientific customer service or your regional sales representative. Volume discounts and institutional pricing may be available upon request.
Frequently asked questions
What is GRIPAP1 and why is it relevant to synaptic research?
GRIPAP1 (also known as GRASP1) is a scaffolding protein that interacts with GRIP proteins and regulates AMPA receptor trafficking and recycling at synapses. It is essential for modulating synaptic plasticity, making it a key target in studies of learning, memory, and glutamatergic signaling.
What applications is Recombinant Human GRIPAP1 Protein suitable for?
This recombinant protein is suitable for protein–protein interaction studies (pull-down, SPR, BLI), antibody validation (ELISA, Western blot), biochemical assays, drug discovery screening, and in vitro cell biology reconstitution experiments. Researchers should confirm functional activity data in the product datasheet before use in activity-dependent assays.
How should Recombinant Human GRIPAP1 Protein be stored to maintain its integrity?
The protein should be stored at the temperature specified in the product datasheet, generally −20 °C or −80 °C for long-term storage. Aliquot the protein into single-use volumes upon receipt to avoid repeated freeze–thaw cycles, which can cause aggregation and reduce activity.
Is a Certificate of Analysis (CoA) available for this product?
Yes, a Certificate of Analysis is provided with each lot of Recombinant Human GRIPAP1 Protein. The CoA includes purity assessment, identity confirmation, and endotoxin data specific to the lot shipped. Contact Aladdin Scientific customer service if you require a copy for a specific lot number.
Can this protein be used for in vivo studies?
Recombinant Human GRIPAP1 Protein (rp370892) is intended for in vitro research use only and is not approved or validated for in vivo administration, diagnostic, or therapeutic purposes. Researchers planning in vivo studies should consult with Aladdin Scientific regarding appropriate product formats and endotoxin specifications.
References
- Bhargava A, et al. GRASP1 (GRIP-associated protein 1) regulates recycling of AMPA receptors. General reference — specific publication details not available in source material.
- Ye B, et al. GRASP1 and the PDZ domain proteins GRIP and ABP form a complex required for glutamate receptor recycling. General reference — specific details not confirmed in source material.
- Dong H, et al. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. General reference — specific publication details not available in source material.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)